Recently, the role of immunotherapy in tumor treatment has been widely investigated, especially for cytotoxic T-lymphocyte associated protein 4 (CTLA-4) and programmed cell death-1 (PD-1) inhibitors. This evidence concerns the gene PDCD1 and neoplasm.